Prevalence, awareness, treatment, and control of hypertension in china. - Wikidata - awgldk - TriplyDB

Prevalence, awareness, treatment, and control of hypertension in china.

Prevalence, awareness, treatment, and control of hypertension in china.

http://www.wikidata.org/entity/Q39637231

about

Non-communicable diseases in sub-Saharan Africa: the case for cohort studies Prevalence of Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis Traditional Risk Factors for Stroke in East Asia Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk Chinese herbal therapy and Western drug use, belief and adherence for hypertension management in the rural areas of Heilongjiang province, China MAGI-1a functions as a scaffolding protein for the distal renal tubular basolateral K+ channels A Targeted Metabolomics MRM-MS Study on Identifying Potential Hypertension Biomarkers in Human Plasma and Evaluating Acupuncture Effects The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart program General practitioners' hypertension knowledge and training needs: a survey in Xuhui district, Shanghai.Tea consumption is inversely related to 5-year blood pressure change among adults in Jiangsu, China: a cross-sectional study.Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study Emilin1 gene and essential hypertension: a two-stage association study in northern Han Chinese population.Male and female adult population health status in China: a cross-sectional national survey.The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010.Metabolic syndrome in the elderly: an overview of the evidence.Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia.Chronic disease prevalence and care among the elderly in urban and rural Beijing, China - a 10/66 Dementia Research Group cross-sectional survey Voltage-dependent anion channel (VDAC) is involved in apoptosis of cell lines carrying the mitochondrial DNA mutation.Prevalence of the metabolic syndrome among rural original adults in NingXia, China.Hypertension detection, management, control and associated factors among residents accessing community health services in Beijing Incidence and predictors of hypertension among rural Chinese adults: results from Liaoning province.Dietary pattern and its association with the prevalence of obesity, hypertension and other cardiovascular risk factors among Chinese older adults.Associations of body mass index with incident hypertension in American white, American black and Chinese Asian adults in early and middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study, the Atherosclerosis Risk in Com Association study of the β2-adrenergic receptor gene polymorphisms and hypertension in the Northern Han Chinese.Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China.The effect of educational programs on hypertension management.Efficacy and safety of valsartan/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study.Molecular characterization of a Chinese family carrying a novel C4329A mutation in mitochondrial tRNAIle and tRNAGln genes.Dietary patterns and blood pressure among middle-aged and elderly Chinese men in Shanghai.Mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree.Failures in mitochondrial tRNAMet and tRNAGln metabolism caused by the novel 4401A>G mutation are involved in essential hypertension in a Han Chinese Family.Epidemiology of hypertension and chronic kidney disease in China Role of leptin receptor gene polymorphisms in susceptibility to the development of essential hypertension: a case-control association study in a Northern Han Chinese population Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: a population-based survey of 58,308 residents.Evaluation of personnel blood pressure and its risk factors in university affiliated medical centers: Iran's Health Day 2013.

P2860

Q21563451-E660F1F7-87B0-4D8F-B0D0-BC767B207C18 Q26774778-B5BC0A1D-9EF5-4648-9527-4E4625A62A2F Q28071330-2706A502-1138-4C6F-AF98-23EB98403869 Q28268669-4CBE9860-CAF8-42F7-80EB-A3ADA9923E15 Q28301585-CF29FB0D-D776-401F-8B07-FB8494F7BCAE Q28543493-CF00EB6C-E19A-45B8-A1B5-31A9CB6C4606 Q28546848-6FDD1B8B-1FBB-4543-8E2B-D1A07C2228BA Q28565130-40625304-FE92-43F1-AFF3-B6FD56A993D7 Q28834202-1D15F222-6B1D-45BA-AAD4-B9E289F5F3E0 Q30497952-5875A430-75D2-4A6D-9FFA-B89D320EA16A Q30534771-06F9F201-1083-4B19-A86B-B33766DEC947 Q30596237-5FB8F147-AE45-40B3-8F22-5D4C2F9912D1 Q30619473-42D0234C-7DC4-42E5-8C98-DF7D84E7F246 Q30726334-3C9EE8EA-79F4-444F-8F01-87622831D82B Q30891520-9F3130BF-365C-4D02-AF5F-7758A0BD4F8E Q33357933-E321BF8E-4EDB-4AE1-8F52-2D43309165E0 Q33387452-F3AD9935-E336-4A52-8AF2-08ADD0322451 Q33401729-BBF7C141-9B98-440A-B9BB-D023D8825466 Q33421460-EEE267A6-3098-4306-8050-CC837D3CDE57 Q33456164-5C5D54C4-BC37-43B0-BE02-C442470D032A Q33511552-EE3028F8-B922-45E5-9690-76C8924F6E89 Q33515437-0E728052-B103-4D8D-B8C8-11CD64A15E19 Q33541340-EBFFAC10-9C69-423C-ADAC-4802623DAAB2 Q33554532-A4798E87-F29F-4745-B50F-4E56269C63E6 Q33594293-CAF70229-FA89-45CB-966C-95D545265EC5 Q33627905-7243D2AC-A74F-47FF-9CCC-B360968B1E34 Q33739705-42B8C18D-D6CE-45C5-9800-385E125750C6 Q33869152-B78282E8-EF75-45E7-9C04-0684B8D5BBE4 Q33898726-206922C6-0B0B-401F-A554-128EAC2EE8A7 Q33942438-FB620ED4-5DBF-491E-9849-02CB6DD58AFF Q33970085-FAC8CEB1-F796-443A-8F71-9F07A01B4DD5 Q33994501-8459CEF2-D0B3-40E7-BC13-9FFD7AC4DB9D Q33996453-9CF12EDC-9A7D-45FA-A501-7942879D8459 Q34007628-C2E02FC5-1C83-4892-A8CB-314A238977D3 Q34007647-2E94DCD0-8DDC-41D6-AB3D-86C3B3C9B8E2 Q34027166-A855BB57-F5A1-41D2-AA89-ACA07B3B2F87 Q34046950-1E850B04-27F4-4D5E-AF46-2B3F1891D419 Q34119726-6C07C618-AA73-4804-9C79-0227DD5CE84A Q34128704-E40B5C34-6F36-45E1-B094-696ED63A63DC Q34131856-FA54F303-7AFC-45C0-9FF5-D8046BB271E6

P2860

Prevalence, awareness, treatment, and control of hypertension in china.

http://www.wikidata.org/entity/Q39637231

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Prevalence, awareness, treatment, and control of hypertension in china.

@en

Prevalence, awareness, treatment, and control of hypertension in china.

@nl

type

label

Prevalence, awareness, treatment, and control of hypertension in china.

@en

Prevalence, awareness, treatment, and control of hypertension in china.

@nl

prefLabel

Prevalence, awareness, treatment, and control of hypertension in china.

@en

Prevalence, awareness, treatment, and control of hypertension in china.

@nl

P1433

Q39637231-341012AC-E0EF-461E-A90C-35C125F2CD21

P1476

Q39637231-9DE864BC-9A41-4C33-B5D5-7936626D25B7

P2093

Q39637231-2870E476-F69A-4943-8FDC-B84186C4C963

Q39637231-35D33AE1-C0FD-4616-A4BD-56EF1AF2AA42

Q39637231-4702C510-02FA-490F-80C6-0F3B4D7722B7

Q39637231-53598E0B-8707-44C8-8673-6D5D1BFF9BEB

Q39637231-6A33B8DF-DF56-4320-8D62-F6CAB28A829C

Q39637231-6BE0E849-C92C-466C-B46F-ECDC838FE61F

Q39637231-6D3C7CC8-96A3-48D1-850C-9197B2F80097

Q39637231-93E19166-5868-4F69-9DC4-17682F5C293E

Q39637231-977BD02E-78BF-47A9-BD40-586E7BB5F7E8

Q39637231-9F9053D7-0DF4-48C5-8212-E3B7D69A33CE

P304

Q39637231-62CFF72C-10EC-41CD-ACB7-174B0188393D

P31

Q39637231-A644373D-08E5-4150-B719-09D3C73EA659

P356

Q39637231-D30EC292-D1D9-4708-BD73-2D3CCCDA9B55

P407

Q39637231-54B8DFA4-3690-4DFA-9C4A-E2A4D6B2620F

P433

Q39637231-B6001EAD-D426-42D9-AB6F-017C3E70E6ED

P478

Q39637231-7899B36E-453D-41E2-B401-E0B17DEDECEE

P577

Q39637231-54543558-EC8F-4E09-AB38-A4CF2CB57842

P698

Q39637231-AB5F0B80-F3FF-4018-BAEB-E570329AAF75

P921

Q39637231-8AC7C2EA-4383-481D-BFF0-8D2EA93DA26F

P356

01.HYP.0000040263.94619.D5

P1433

P1476

Prevalence, awareness, treatment, and control of hypertension in china.

@en

P2093

Dongfeng Gu

http://www.w3.org/2001/XMLSchema#string

Guanyong Huang

http://www.w3.org/2001/XMLSchema#string

InterASIA Collaborative Group. ...... Cardiovascular Disease in ASIA

http://www.w3.org/2001/XMLSchema#string

Jiang He

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Kristi Reynolds

http://www.w3.org/2001/XMLSchema#string

Paul K Whelton

http://www.w3.org/2001/XMLSchema#string

Paul Muntner

http://www.w3.org/2001/XMLSchema#string

Robert F Reynolds

http://www.w3.org/2001/XMLSchema#string

Shaoyong Su

http://www.w3.org/2001/XMLSchema#string

P304

920-927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.HYP.0000040263.94619.D5

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12468580

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension